THE VALUE OF MAGNETIC RESONANCE IMAGING IN PREDICTING RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN RECTAL CANCER

Thanh Ngọc Lâm, Trương Quỳnh Giang Lê, Thị Thanh Thiên Nguyễn, Tấn Đức Võ

Main Article Content

Abstract

Objective: To determine independent predictive factors and a prediction model for a pathological complete response in rectal cancer following neoadjuvant chemoradiotherapy. Methods: A cross-sectional descriptive study was conducted on 92 rectal cancer patients who underwent MRI before long-course NCRT, followed by surgery and pathological examination at the University of Medicine and Pharmacy Hospital in Ho Chi Minh City. Results: Independent predictive factors for a complete response to neoadjuvant chemoradiotherapy included MRI features such as a maximum tumor area of ≤ 5.2 cm² (OR = 5.3) and the number of lymph nodes meeting imaging criteria for metastasis (OR = 0.77). A prognostic model combining both the maximum tumor area and the number of lymph nodes meeting imaging criteria for metastasis showed good predictive value, with an area under the curve (AUC) of 0.812, sensitivity of 70%, specificity of 80.6%, accuracy of 78.3%, positive predictive value of 50%, and negative predictive value of 90.6%. Conclusions: Pre-treatment MRI imaging is valuable in predicting the potential for a complete response to neoadjuvant chemoradiotherapy in rectal cancer, providing useful information for treatment decision-making.

Article Details

References

Beets-Tan RGH, Lambregts DMJ, Maas M, et al. Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. European Radiology. 2018;28(4):1465-1475. doi:10.1007/ s00330-017-5026-2
2. Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63. doi:10.3322/caac.21834
3. Han YD, Kim WR, Park SW, et al. Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation. Medicine (Baltimore). 2015;94(45):e1971. doi:10.1097/MD. 0000000000001971
4. Huang CM, Huang MY, Huang CW, et al. Machine learning for predicting pathological complete response in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy. Sci Rep. 2020;10(1):12555. doi:10.1038/s41598-020-69345-9
5. Huh JW, Kim HR, Kim YJ. Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer. Dis Colon Rectum. 2013;56(6):698–703. doi:10.1097/DCR. 0b013e3182837e5b
6. Martin ST, Heneghan HM, Winter DC. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg. 2012;99(7):918–28. doi:10.1002/ bjs.8702
7. Sathyakumar K, Chandramohan A, Masih D, Jesudasan MR, Pulimood A, Eapen A. Best MRI predictors of complete response to neoadjuvant chemoradiation in locally advanced rectal cancer. Br J Radiol. 2016;89(1060): 20150328. doi:10.1259/bjr.20150328
8. Yardimci AH, Kocak B, Sel I, et al. Radiomics of locally advanced rectal cancer: machine learning-based prediction of response to neoadjuvant chemoradiotherapy using pre-treatment sagittal T2-weighted MRI. Jpn J Radiol. 2023; 41(1):71–82. doi:10.1007/s11604-022-01325-7
9. Zhang C, Ye F, Liu Y, Ouyang H, Zhao X, Zhang H. Morphologic predictors of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Oncotarget. 2018;9(4):4862–74. doi:10. 18632/oncotarget.23419